The query "Ganirelix meitheal" appears to be a misspelling or an incomplete query. Assuming the user is interested in information about Ganirelix, here is a breakdown of related topics.
What is Ganirelix?
Ganirelix is a synthetic decapeptide that is an antagonist of gonadotropin-releasing hormone (GnRH) [1]. It is used in assisted reproductive technology (ART), specifically in controlled ovarian stimulation, to prevent premature luteinizing hormone (LH) surges in women undergoing treatment [2]. By blocking GnRH receptors, Ganirelix suppresses the pituitary gland's release of LH and follicle-stimulating hormone (FSH) [3].
How is Ganirelix administered?
Ganirelix is administered via subcutaneous injection [1]. It is typically given once daily, starting on the morning of the sixth day of stimulation and continuing until the day of human chorionic gonadotropin (hCG) administration [4].
What is the mechanism of action for Ganirelix?
Ganirelix works by competitively binding to GnRH receptors in the anterior pituitary gland. This binding prevents endogenous GnRH from accessing its receptors, thereby inhibiting the pulsatile release of LH and FSH. This suppression is crucial for preventing ovulation from occurring too early during ovarian stimulation cycles, allowing more time for follicle development [2][3].
When is Ganirelix used in fertility treatment?
Ganirelix is a component of ovulation induction protocols used in in vitro fertilization (IVF) and other ART procedures [2]. It is typically initiated after a certain number of days of FSH stimulation, as determined by the patient's response and the clinician's protocol [4].
What are the potential side effects of Ganirelix?
Common side effects reported with Ganirelix include local reactions at the injection site, such as redness, itching, and swelling [1]. Systemic side effects are generally infrequent but can include headache and nausea [1].
Are there alternatives to Ganirelix for preventing premature LH surges?
Another class of GnRH analogs, GnRH agonists, can also be used to prevent premature LH surges. These agonists, when used in a "down-regulation" protocol, initially stimulate GnRH receptors, leading to a surge in LH and FSH, followed by receptor desensitization and suppression [3]. The choice between GnRH antagonists like Ganirelix and GnRH agonists depends on individual patient factors, physician preference, and specific treatment protocols [3].
What is the typical cost of Ganirelix?
The cost of Ganirelix can vary significantly based on the pharmacy, dosage, and whether insurance coverage is available [5]. It is often purchased as part of a complete fertility treatment cycle.
Who manufactures Ganirelix?
Ganirelix is marketed under brand names such as Antagon and Orgalutran by different pharmaceutical companies. The original developer and marketer of Antagon was Ares Trading NV, a subsidiary of Solvay Pharmaceuticals, which was later acquired by Abbott Laboratories [6][7].
Sources
1. https://www.drugs.com/ganirelix.html
2. https://www.ncbi.nlm.nih.gov/books/NBK279024/
3. https://www.fertstert.org/article/S0015-0282(02)03029-9/fulltext
4. https://www.reproductivefacts.org/news-and-publications/patient-fact-sheets/medications-used-in-ivf/
5. https://www.goodrx.com/ganirelix
6. https://www.fiercepharma.com/pharma/abbott-acquires-solvay-pharma-21b-deal
7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439384/